Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Advances in small-molecule drug discovery for triple-negative breast cancer

Fosu-Mensah, Nelly, Peris, María Sánchez, Weeks, Hoi Ping, Cai, Jun and Westwell, Andrew David 2015. Advances in small-molecule drug discovery for triple-negative breast cancer. Future Medicinal Chemistry 7 (15) , pp. 2019-2039. 10.4155/fmc.15.129

[thumbnail of Advances in Small Molecule Drug Discovery for Triple-Negative Breast Cancer.pdf]
PDF - Accepted Post-Print Version
Download (1MB) | Preview


Triple-negative breast cancer (TNBC) is a subtype of poor prognosis, highly invasive and difficult-to-treat breast cancers accounting for approximately 15% of clinical cases. Given the poor outlook and lack of sustained response to conventional therapies, TNBC has been the subject of intense studies on new therapeutic approaches in recent years. The development of targeted cancer therapies, often in combination with established chemotherapy, has been applied to a number of new clinical studies in this setting in recent years. This review will highlight recent therapeutic advances in TNBC, focusing on small-molecule drugs and their associated biological mechanisms of action, and offering the possibility of improved prospects for this patient group in the near future.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Subjects: R Medicine > RM Therapeutics. Pharmacology
Publisher: Future Science Ltd
ISSN: 1756-8919
Date of First Compliant Deposit: 30 March 2016
Date of Acceptance: 4 August 2015
Last Modified: 28 Jun 2019 04:38

Citation Data

Cited 11 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics